YM178
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Urinary Bladder, Overactive
Conditions
Urinary Bladder, Overactive
Trial Timeline
Dec 1, 2008 → Mar 1, 2010
NCT ID
NCT00840645About YM178
YM178 is a phase 3 stage product being developed by Astellas Pharma for Urinary Bladder, Overactive. The current trial status is completed. This product is registered under clinical trial identifier NCT00840645. Target conditions include Urinary Bladder, Overactive.
What happened to similar drugs?
9 of 20 similar drugs in Urinary Bladder, Overactive were approved
Approved (9) Terminated (0) Active (11)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00337090 | Phase 2 | Completed |
| NCT01720212 | Phase 1 | Completed |
| NCT01334905 | Phase 1 | Completed |
| NCT00965926 | Phase 1 | Completed |
| NCT00840645 | Phase 3 | Completed |
| NCT00750620 | Phase 1 | Completed |
Competing Products
20 competing products in Urinary Bladder, Overactive